{"id":59457,"date":"2024-11-06T14:41:29","date_gmt":"2024-11-06T13:41:29","guid":{"rendered":"https:\/\/www.cmtc.nl\/pedia\/ovm\/pros-pik3ca-related-overgrowth-spectrum\/"},"modified":"2026-01-23T15:54:47","modified_gmt":"2026-01-23T14:54:47","slug":"pros-pik3ca-related-overgrowth-spectrum","status":"publish","type":"page","link":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/","title":{"rendered":"PROS (PIK3CA-Related Overgrowth Spectrum)"},"content":{"rendered":"<p><span style=\"font-size: revert; color: initial; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, 'Noto Sans', sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\">PROS, or &#8220;PIK3CA-Related Overgrowth Spectrum,&#8221; is a group of conditions caused by changes in the PIK3CA gene. This gene plays a role in cell growth and development. A mutation in this gene can cause certain cells to grow too quickly or excessively, leading to tissue and organ overgrowth. The severity and type of overgrowth can vary from person to person, depending on where in the body the mutation has an effect.<\/span><\/p>\n<div class=\"flex-1 overflow-hidden @container\/thread\">\n<div class=\"h-full\">\n<div class=\"react-scroll-to-bottom--css-pwqyp-79elbk h-full\">\n<div class=\"react-scroll-to-bottom--css-pwqyp-1n7m0yu\">\n<div class=\"flex flex-col text-sm\">\n<article class=\"w-full scroll-mb-[var(--thread-trailing-height,150px)] text-token-text-primary focus-visible:outline-2 focus-visible:outline-offset-[-4px]\" dir=\"auto\" data-testid=\"conversation-turn-21\" data-scroll-anchor=\"true\">\n<div class=\"m-auto text-base py-[18px] px-3 md:px-4 w-full md:px-5 lg:px-4 xl:px-5\">\n<div class=\"mx-auto flex flex-1 gap-4 text-base md:gap-5 lg:gap-6 md:max-w-3xl lg:max-w-[40rem] xl:max-w-[48rem]\">\n<div class=\"group\/conversation-turn relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex-col gap-1 md:gap-3\">\n<div class=\"flex max-w-full flex-col flex-grow\">\n<div class=\"min-h-8 text-message flex w-full flex-col items-end gap-2 whitespace-normal break-words text-start [.text-message+&amp;]:mt-5\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"fbfcecd2-c92a-45c3-b1ef-a3006110f108\" data-message-model-slug=\"gpt-4o\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[3px]\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<h3>Key Features<\/h3>\n<p>People with PROS may experience various symptoms, including:<\/p>\n<ul>\n<li>Overgrowth of limbs, skin, or organs: Growth may be uneven, such as one arm or leg being larger than the other.<\/li>\n<li>Vascular issues: Abnormal blood vessel growth can lead to hemangiomas (benign vascular tumors), lymphatic malformations, and other complications.<\/li>\n<li>Facial or cranial abnormalities: Some individuals may have asymmetrical growth of the skull or face.<\/li>\n<li>Other physical complaints: Potential problems include pain, fatigue, or difficulty moving, depending on the location and extent of the overgrowth.<\/li>\n<\/ul>\n<h3>Causes<\/h3>\n<p>PROS is caused by a change (mutation) in the PIK3CA gene. This mutation occurs randomly after conception and is not inherited from the parents. It is not a hereditary condition. The mutation is typically present in only a portion of the body\u2019s cells, meaning that some tissues and organs have the mutation while others do not. This phenomenon is called &#8220;mosaicism.&#8221;<\/p>\n<h3>Diagnosis<\/h3>\n<p>The diagnosis of PROS is based on physical features and genetic testing to confirm the PIK3CA mutation. A specialist often uses imaging techniques (such as MRI) and genetic testing to establish the condition.<\/p>\n<h3>Treatment<\/h3>\n<p>There is currently no cure for PROS, but treatments exist to manage symptoms and complications:<\/p>\n<ul>\n<li>Surgical procedures: Surgeries may be performed to reduce overgrowth or relieve pain and other symptoms.<\/li>\n<li>Medication: Research is ongoing into drugs that can inhibit the PIK3CA pathway, such as alpelisib, to reduce overgrowth.<\/li>\n<li>Supportive care: Physical therapy, occupational therapy, and psychological support can help improve quality of life.<\/li>\n<\/ul>\n<h3>Living with PROS<\/h3>\n<p>PROS can have a significant impact on daily life. Regular medical monitoring is essential to address issues promptly. Families may benefit from working with specialized teams and connecting with patient organizations for support and information.<\/p>\n<h3>Summary<\/h3>\n<p>PROS is a rare, non-hereditary condition that causes excessive tissue growth due to a mutation in the PIK3CA gene. The condition is complex and varies greatly from person to person. While there is no cure yet, various treatments can help manage symptoms and improve quality of life.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2>Diseases related to PIK3CA gene mutations<\/h2>\n<p>PIK3CA gene mutations are associated with a variety of conditions that fall under the PIK3CA-Related Overgrowth Spectrum (PROS). These conditions are caused by somatic mutations in the PIK3CA gene and are characterized by abnormal tissue growth, often combined with other symptoms. Below are some conditions commonly associated with PROS, including their full names and abbreviations:<\/p>\n<ol>\n<li><a href=\"https:\/\/www.cmtc.nl\/en\/pedia\/ovm\/cloves\/\" target=\"_blank\" rel=\"noopener\">CLOVES Syndrome<\/a> (Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Skeletal\/Scoliosis abnormalities): Congenital overgrowth of fatty tissue, vascular malformations, skin abnormalities, and skeletal issues.<\/li>\n<li>MCAP Syndrome (Megalencephaly-Capillary Malformation Syndrome): Characterized by abnormally enlarged brains (megalencephaly), capillary malformations, and often neurological issues.<\/li>\n<li><a href=\"https:\/\/www.cmtc.nl\/en\/pedia\/ovm\/klippel-trenaunay\/\" target=\"_blank\" rel=\"noopener\">Klippel-Tr\u00e9naunay Syndrome<\/a> (KTS): Overgrowth of tissues and vascular abnormalities such as capillary, venous, and lymphatic malformations.<\/li>\n<li><a href=\"https:\/\/www.cmtc.nl\/en\/pedia\/ovm\/diffuse-capillary-malformation-with-overgrowth-dcmo\/\" target=\"_blank\" rel=\"noopener\">DCMO<\/a> (Diffuse Capillary Malformation with Overgrowth): Diffuse capillary malformations combined with asymmetrical overgrowth.<\/li>\n<li>FAVA (Fibroadipose Vascular Anomaly): A condition with fibroadipose overgrowth combined with vascular anomalies.<\/li>\n<li>FIL (Facial Infiltrating Lipomatosis): Fatty tissue infiltrating facial structures, causing asymmetrical overgrowth.<\/li>\n<li>HMEG (Hemimegalencephaly): Abnormal enlargement of one hemisphere of the brain, often associated with seizures and cognitive issues.<\/li>\n<\/ol>\n<p>These conditions are rare and can present significant medical and psychological challenges. Genetic testing is often used to better understand and provide personalized treatment for these disorders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PROS, or &#8220;PIK3CA-Related Overgrowth Spectrum,&#8221; is a group of conditions caused by changes in the PIK3CA gene. This gene plays a role in cell growth and development. A mutation in this gene can cause certain cells to grow too quickly or excessively, leading to tissue and organ overgrowth. The severity and type of overgrowth can [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":59448,"parent":72878,"menu_order":12,"comment_status":"closed","ping_status":"closed","template":"aw-modules\/awcf_create_page_templates_with_elementor_content\/page-templates\/page-aw-page-template-67351.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-59457","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM\" \/>\n<meta property=\"og:description\" content=\"PROS, or &#8220;PIK3CA-Related Overgrowth Spectrum,&#8221; is a group of conditions caused by changes in the PIK3CA gene. This gene plays a role in cell growth and development. A mutation in this gene can cause certain cells to grow too quickly or excessively, leading to tissue and organ overgrowth. The severity and type of overgrowth can [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/\" \/>\n<meta property=\"og:site_name\" content=\"CMTC-OVM\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T14:54:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/\",\"url\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/\",\"name\":\"PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM\",\"isPartOf\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp\",\"datePublished\":\"2024-11-06T13:41:29+00:00\",\"dateModified\":\"2026-01-23T14:54:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage\",\"url\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp\",\"contentUrl\":\"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cmtc.nl\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pedia\",\"item\":\"https:\/\/www.cmtc.nl\/en\/pedia\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"PROS (PIK3CA-Related Overgrowth Spectrum)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cmtc.nl\/en\/#website\",\"url\":\"https:\/\/www.cmtc.nl\/en\/\",\"name\":\"CMTC-OVM\",\"description\":\"Global non-profit patient organisation\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cmtc.nl\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/","og_locale":"en_US","og_type":"article","og_title":"PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM","og_description":"PROS, or &#8220;PIK3CA-Related Overgrowth Spectrum,&#8221; is a group of conditions caused by changes in the PIK3CA gene. This gene plays a role in cell growth and development. A mutation in this gene can cause certain cells to grow too quickly or excessively, leading to tissue and organ overgrowth. The severity and type of overgrowth can [&hellip;]","og_url":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/","og_site_name":"CMTC-OVM","article_modified_time":"2026-01-23T14:54:47+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/","url":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/","name":"PROS (PIK3CA-Related Overgrowth Spectrum) - CMTC-OVM","isPartOf":{"@id":"https:\/\/www.cmtc.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage"},"image":{"@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp","datePublished":"2024-11-06T13:41:29+00:00","dateModified":"2026-01-23T14:54:47+00:00","breadcrumb":{"@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#primaryimage","url":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp","contentUrl":"https:\/\/www.cmtc.nl\/wp-content\/uploads\/2024\/12\/simplified-graphical-representation-of-the-pik3ca-gene.webp","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/pros-pik3ca-related-overgrowth-spectrum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cmtc.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Pedia","item":"https:\/\/www.cmtc.nl\/en\/pedia\/"},{"@type":"ListItem","position":3,"name":"Conditions","item":"https:\/\/www.cmtc.nl\/en\/pedia\/conditions\/"},{"@type":"ListItem","position":4,"name":"PROS (PIK3CA-Related Overgrowth Spectrum)"}]},{"@type":"WebSite","@id":"https:\/\/www.cmtc.nl\/en\/#website","url":"https:\/\/www.cmtc.nl\/en\/","name":"CMTC-OVM","description":"Global non-profit patient organisation","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cmtc.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/pages\/59457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/comments?post=59457"}],"version-history":[{"count":5,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/pages\/59457\/revisions"}],"predecessor-version":[{"id":75597,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/pages\/59457\/revisions\/75597"}],"up":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/pages\/72878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/media\/59448"}],"wp:attachment":[{"href":"https:\/\/www.cmtc.nl\/en\/wp-json\/wp\/v2\/media?parent=59457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}